Patent ID: 7947303

Claim:
A method of using a supplement comprising the step of administering the supplement to a patient enterally for treatment of malnutrition or major abdominal surgery, for the treatment of patients who must be fasted before diagnostic procedures or before surgical interventions, for the treatment of inflammatory bowel disorders, mucositis, stomatitis, short-bowel syndrome or acute pancreatitis, wherein the supplement comprises, as solution, in each case based on a daily dose: a) glutamine and/or glutamine precursor selected from the group consisting of glutamine esters, glutamine amides, N-alkylated glutamines, glutamine salts, keto precursors of glutamine and short-chain, glutamine-containing peptides, in a first amount in the range from 15 to 70 g, where in the case of glutamine precursors said first amount is based on the glutamine content thereof, b) at least two representatives from the group of substances having antioxidant activity selected from the group consisting of vitamins, amino acids, amino acid derivatives amino sulfonic acid trace elements, polyphenols and carotenoids and c) short-chain fatty acids having two to five carbon atoms and/or salts or esters as precursors of short-chain fatty acids having two to five carbon atoms, in a second amount of from 0.5 to 10 g, where in the case of precursors of short-chain fatty acids said second amount is based on the short-chain fatty acid content thereof and wherein said daily dose is 200 to 1000 ml, and the supplement has a total energy content of no more than 1000 kcal/200 ml.